Cantor Fitzgerald Downgrades Aravive to Neutral, Lowers Price Target to $0.25
Portfolio Pulse from richadhand@benzinga.com
Cantor Fitzgerald analyst Louise Chen has downgraded Aravive (NASDAQ:ARAV) from Overweight to Neutral and lowered the price target from $18 to $0.25.

August 22, 2023 | 11:57 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Aravive's stock rating has been downgraded from Overweight to Neutral by Cantor Fitzgerald, with a significant reduction in price target from $18 to $0.25.
The downgrade from Overweight to Neutral indicates a less optimistic outlook for the company's stock. The drastic reduction in price target from $18 to $0.25 suggests that the analyst expects a significant decrease in the stock's value. This could potentially lead to a sell-off, negatively impacting the stock's price in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100